The meeting of the Advisory Committee on Immunization Practices will likely be filled with misinformation and vaccine myths, experts warn.
The universal HBV birth dose has prevented an estimated 90,100 childhood deaths since 1991, but a federal vaccine advisory group may vote to end the practice.
Analysis of more than 400 studies reveals no evidence that delaying the universal hepatitis B vaccine birth dose improves safety or effectiveness.
Officials warn rising drug resistance could undo decades of progress in controlling HIV, hepatitis, and sexually transmitted infections.
The list offers the clearest view yet of the Trump administration's plans for the agency under HHS Secretary Robert F. Kennedy Jr.
Over 40% appear to have received no treatment for their infection, a gap especially apparent in women and Black or White patients.
The review will look at decades of data on the safety, efficacy, and public health impact of administering the hepatitis B shot at birth.
The authors noted that viral infections trigger the immune system to release substances that lead to inflammation and increase the risk of blood clots.
One study found fairly high rates of flu, mumps, and hepatitis A, and the other found that only 28% of adults have been vaccinated against tetanus and diphtheria.
Whooping cough cases in Florida have risen by 81% this year compared with 2024.
